Wilprafen in treatment of the chronic urogenital chlamydiosis
The treatment of 40 patients with chronic urogenital chlamydiosis with Wilprafenom (500 mg 2 times a day during 21 days) in combination with the drug interleukin-beta, systemic enzyme therapy, physiotherapy and adequate local treatment was made. The clinical cure was achieved in 36 (90%), an improve...
Saved in:
| Main Authors: | V. A. Molochkov, A. E. Gushchin, E. V. Balyura |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2013-03-01
|
| Series: | Сеченовский вестник |
| Subjects: | |
| Online Access: | https://www.sechenovmedj.com/jour/article/view/705 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
UROGENITAL CHLAMYDIOSIS: CURRENT STATE (REVIEW)
by: T. A. Volodina, et al.
Published: (2015-09-01) -
Optimal control and cost-effectiveness of the control strategies chlamydiosis
by: Yustina Amon Liana
Published: (2025-06-01) -
Hematological parameters and immune response characteristics in canine chlamydiosis
by: V. V. Bisiuk, et al.
Published: (2025-03-01) -
Preliminary Evidence of Chlamydiosis in Koalas of the Greater Geelong Region, Victoria: A Potential Emerging Threat?
by: Gianna Kramer, et al.
Published: (2025-07-01) -
The Urogenital System Microbiota: Is It a New Gamechanger in Urogenital Cancers?
by: Gülfem Ece, et al.
Published: (2025-02-01)